Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Gastroenterology

How It Works: Autoimmune vs. Environmental Gastritis

At a Glance

Chronic atrophic gastritis can be autoimmune, usually affecting acid-producing cells in the stomach body, or environmental, often linked to H. pylori and patchy damage. Biopsy findings, history, and blood tests help identify the pattern and guide risk monitoring.

Diagnostic Tests to Discuss: Complete Blood Count (CBC), ferritin and iron studies, Vitamin B12 (with MMA when appropriate), intrinsic-factor/parietal-cell antibodies, gastrin (with medication context), thyroid testing, and reliable H. pylori testing. These are tests to discuss with your doctor, not a mandatory panel for everyone.

To understand chronic atrophic gastritis (CAG), it helps to think of your stomach as a specialized factory. In a healthy stomach, the “workers” are parietal cells, located mainly in the upper part (the corpus and fundus). These cells produce hydrochloric acid to break down food, and they create intrinsic factor, a protein that allows your body to absorb Vitamin B12 [1][2].

In atrophic gastritis, these parietal cells are damaged. Without them, the stomach may become less acidic and lose its ability to process essential nutrients [3][4]. Doctors generally group atrophic gastritis into two categories based on what is causing the damage, though overlapping disease can occur. The biopsy pattern, history, and laboratory tests determine the likely cause.

Two Paths to Atrophy: AMAG vs. EMAG

Feature Autoimmune (AMAG) Environmental (EMAG)
Primary Cause T-cell mediated injury [5] H. pylori infection [6]
Primary Target Parietal cells (acid/intrinsic factor producers) [2] General stomach lining [7]
Location Usually body/top (corpus-predominant) [8] Often patchy (multifocal) [6]
Main Risks Type 1 NETs, Pernicious Anemia, Gastric Cancer [9] Stomach Adenocarcinoma [7]

Autoimmune Metaplastic Atrophic Gastritis (AMAG)

In AMAG, your immune system mistakenly identifies your parietal cells as “invaders.” T-cell mediated injury damages the cells, and the body produces diagnostic markers called anti-parietal cell antibodies [5][10]. Because parietal cells are mainly found in the top and middle of the stomach, the damage is usually restricted to those areas [8].

Environmental Metaplastic Atrophic Gastritis (EMAG)

In EMAG, the damage is usually caused by a long-term infection with the bacterium H. pylori [6]. This chronic inflammation is often “multifocal,” meaning it occurs in patches [8]. Both forms of atrophic gastritis can increase the risk of adenocarcinoma [7].

The Feedback Loop: Why Gastrin Matters

One of the most important differences in AMAG is a biological feedback loop.

Normally, stomach acid suppresses the release of a hormone called gastrin [11]. When parietal cells are lost and acid decreases, this suppression is reduced, leading to increased gastrin production [9][12]. Note that PPIs and other acid-suppressing medicines can also raise gastrin, making tests difficult to interpret without context.

This state of hypergastrinemia (excess gastrin) has an unintended side effect. Constant stimulation causes ECL cells to multiply rapidly, a process called hyperplasia [13]. Over time, these overgrown ECL cells can form small tumors called Type 1 Neuroendocrine Tumors (NETs) [9][14].

The Thyroid Connection

If you have the autoimmune form (AMAG), your doctor may also want to check your thyroid. This is because of a phenomenon called thyrogastric syndrome [15].

The immune system’s tendency to attack the stomach is often linked to other autoimmune conditions, most commonly Hashimoto’s thyroiditis [16]. Research shows that a substantial portion of people with autoimmune gastritis also have autoimmune thyroid disease [15]. Depending on your clinical presentation, your doctor may recommend thyroid-function assessment (such as a TSH or free T4 test) without implying every patient needs antibody testing [17][16].

Understanding whether your gastritis is autoimmune or environmental helps determine which risks your doctor will monitor and how they will manage your long-term health [18].

Common questions in this guide

What is the difference between autoimmune and environmental atrophic gastritis?
Autoimmune atrophic gastritis occurs when the immune system damages acid- and intrinsic-factor-producing parietal cells, usually in the body and upper part of the stomach. Environmental atrophic gastritis is most often linked to long-term H. pylori infection and tends to cause patchy or multifocal stomach damage. Biopsy findings, medical history, and laboratory tests help determine the more likely pattern.
Which tests can help identify the type of atrophic gastritis I have?
Your doctor may consider a complete blood count, ferritin and iron studies, vitamin B12 with methylmalonic acid when appropriate, parietal-cell or intrinsic-factor antibodies, gastrin with medication context, thyroid testing, and reliable H. pylori testing. These tests are not a mandatory panel for everyone; the appropriate evaluation depends on your biopsy, history, symptoms, and medications.
Why can gastrin be high in autoimmune atrophic gastritis?
When parietal cells are lost, the stomach produces less acid, so there is less acid-related suppression of gastrin. Persistently high gastrin can stimulate ECL cells and contribute to Type 1 neuroendocrine tumors. Proton pump inhibitors and other acid-suppressing medicines can also raise gastrin, so medication use matters when the result is interpreted.
Is autoimmune atrophic gastritis linked to thyroid disease?
Yes. Autoimmune atrophic gastritis can occur alongside other autoimmune conditions, especially Hashimoto’s thyroiditis. Depending on your clinical situation, your doctor may recommend thyroid-function tests such as TSH or free T4; this does not mean that every patient needs thyroid antibody testing.
Can an H. pylori test be negative even when atrophic gastritis is present?
A negative H. pylori result should be interpreted in the context of your testing method, medications, biopsy findings, and stomach environment. Ask your doctor whether the test was reliable and whether repeat or different testing is appropriate if the cause of the gastritis remains uncertain.
What risks are associated with chronic atrophic gastritis?
Autoimmune atrophic gastritis can be associated with vitamin B12-related pernicious anemia and Type 1 neuroendocrine tumors. Both autoimmune and environmental forms can increase the risk of stomach adenocarcinoma, so your doctor may recommend monitoring based on your findings and overall risk.

Get notified when new evidence is published on chronic atrophic gastritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    The Physiology of the Gastric Parietal Cell.

    Engevik AC, Kaji I, Goldenring JR

    Physiological reviews 2020; (100(2)):573-602 doi:10.1152/physrev.00016.2019.

    PMID: 31670611
  2. 2

    Pathophysiology and laboratory diagnosis of pernicious anemia.

    Toh BH

    Immunologic research 2017; (65(1)):326-330 doi:10.1007/s12026-016-8841-7.

    PMID: 27538411
  3. 3

    Functional anatomy and physiology of gastric secretion.

    Schubert ML

    Current opinion in gastroenterology 2015; (31(6)):479-85 doi:10.1097/MOG.0000000000000213.

    PMID: 26376477
  4. 4

    Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review.

    Cavalcoli F, Zilli A, Conte D, Massironi S

    World journal of gastroenterology 2017; (23(4)):563-572 doi:10.3748/wjg.v23.i4.563.

    PMID: 28216963
  5. 5

    Autoimmune gastritis: Pathologist's viewpoint.

    Coati I, Fassan M, Farinati F, et al.

    World journal of gastroenterology 2015; (21(42)):12179-89 doi:10.3748/wjg.v21.i42.12179.

    PMID: 26576102
  6. 6

    Atrophic gastritis of distinct etiologies: malignant potential in Helicobacter pylori-associated and autoimmune forms.

    Rokkas T, Rugge M

    Annals of gastroenterology 2026; (39(3)):283-293 doi:10.20524/aog.2026.1065.

    PMID: 42164610
  7. 7

    Induction and Regulation of the Innate Immune Response in Helicobacter pylori Infection.

    Gobert AP, Wilson KT

    Cellular and molecular gastroenterology and hepatology 2022; (13(5)):1347-1363 doi:10.1016/j.jcmgh.2022.01.022.

    PMID: 35124288
  8. 8

    Autoimmune atrophic gastritis: current perspectives.

    Minalyan A, Benhammou JN, Artashesyan A, et al.

    Clinical and experimental gastroenterology 2017; (10()):19-27 doi:10.2147/CEG.S109123.

    PMID: 28223833
  9. 9

    Progression From Antral G-Cell Hyperplasia to Gastric Neuroendocrine Tumor in a Patient With Autoimmune Gastritis.

    Brown P, Tetali B, Suresh S, Varma A

    ACG case reports journal 2021; (8(8)):e00649 doi:10.14309/crj.0000000000000649.

    PMID: 34476276
  10. 10

    AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.

    Shah SC, Piazuelo MB, Kuipers EJ, Li D

    Gastroenterology 2021; (161(4)):1325-1332.e7 doi:10.1053/j.gastro.2021.06.078.

    PMID: 34454714
  11. 11

    Gastric Peptides-Gastrin and Somatostatin.

    Schubert ML, Rehfeld JF

    Comprehensive Physiology 2019; (10(1)):197-228 doi:10.1002/cphy.c180035.

    PMID: 31853955
  12. 12

    Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.

    Sundaresan S, Kang AJ, Hayes MM, et al.

    Gut 2017; (66(6)):1012-1021 doi:10.1136/gutjnl-2015-310928.

    PMID: 26860771
  13. 13

    Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion.

    Schubert ML

    Current opinion in gastroenterology 2017; (33(6)):430-438 doi:10.1097/MOG.0000000000000392.

    PMID: 28787289
  14. 14

    Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO).

    Lenti MV, Miceli E, Lahner E, et al.

    The American journal of gastroenterology 2024; (119(12)):2408-2417 doi:10.14309/ajg.0000000000002948.

    PMID: 38976374
  15. 15

    Hashimoto's Thyroiditis and Autoimmune Gastritis.

    Cellini M, Santaguida MG, Virili C, et al.

    Frontiers in endocrinology 2017; (8()):92 doi:10.3389/fendo.2017.00092.

    PMID: 28491051
  16. 16

    Thyro-entero-gastric autoimmunity: Pathophysiology and implications for patient management.

    Lahner E, Conti L, Cicone F, et al.

    Best practice & research. Clinical endocrinology & metabolism 2020; (34(1)):101373 doi:10.1016/j.beem.2019.101373.

    PMID: 31864909
  17. 17

    A current clinical overview of atrophic gastritis.

    Annibale B, Esposito G, Lahner E

    Expert review of gastroenterology & hepatology 2020; (14(2)):93-102 doi:10.1080/17474124.2020.1718491.

    PMID: 31951768
  18. 18

    Update on Serum Biomarkers in Autoimmune Atrophic Gastritis.

    Dottori L, Pivetta G, Annibale B, Lahner E

    Clinical chemistry 2023; (69(10)):1114-1131 doi:10.1093/clinchem/hvad082.

    PMID: 37680186

This page is for informational purposes only and does not constitute medical advice. Your gastroenterologist and pathologist should interpret your biopsy and test results and advise you about H. pylori, thyroid, and gastrin evaluation.

Guide contents chronic atrophic gastritis
Research & Literature
02 Symptoms, Warning Signs & When to Seek Urgent Care 04 Decoding Your Pathology Report and Staging